These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 31771681)

  • 1. Heart failure biomarker levels correlate with invasive haemodynamics in pulmonary valve replacement.
    Zegelbone PM; Ringel RE; Coulson JD; Nies MK; Stabler ME; Brown JR; Everett AD
    Cardiol Young; 2020 Jan; 30(1):50-54. PubMed ID: 31771681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NT-proBNP as Marker of Ventricular Dilatation and Pulmonary Regurgitation After Surgical Correction of Tetralogy of Fallot: A MRI Validation Study.
    Paolino A; Hussain T; Pavon A; Velasco MN; Uribe S; Ordoñez A; Valverde I
    Pediatr Cardiol; 2017 Feb; 38(2):324-331. PubMed ID: 27872995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-proBNP Indicates Left Ventricular Impairment and Adverse Clinical Outcome in Patients With Tetralogy of Fallot and Pulmonary Regurgitation.
    Westhoff-Bleck M; Kornau F; Haghikia A; Horke A; Bertram H; Treptau J; Widder J; Bauersachs J; Brehm MU
    Can J Cardiol; 2016 Oct; 32(10):1247.e29-1247.e36. PubMed ID: 26927857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation.
    Dodge-Khatami A; Büchel EV; Knirsch W; Kadner A; Rousson V; Dave HH; Bauersfeld U; Prêtre R
    Ann Thorac Surg; 2006 Sep; 82(3):983-8. PubMed ID: 16928520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of pulmonary valve replacement on ventricular function and cardiac events in patients with tetralogy of Fallot. A retrospective cohort study.
    Ruperti-Repilado FJ; Haag N; Fischer T; Santos Lopes B; Meier L; Wustmann K; Bonassin F; Attenhofer Jost C; Schwitz F; Schwerzmann M; Tobler D; von Felten S; Greutmann M
    Rev Esp Cardiol (Engl Ed); 2024 May; 77(5):408-417. PubMed ID: 38048843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between plasma N-terminal pro-brain natriuretic peptide levels and changes in New York Heart Association functional class, left atrial size, left ventricular size and function after mitral and/or aortic valve replacement.
    Elasfar A
    Ann Saudi Med; 2012; 32(5):469-72. PubMed ID: 22871614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary valve replacement in chronic pulmonary regurgitation in adults with congenital heart disease: impact of preoperative QRS-duration and NT-proBNP levels on postoperative right ventricular function.
    Westhoff-Bleck M; Girke S; Breymann T; Lotz J; Pertschy S; Tutarel O; Roentgen P; Bertram H; Wessel A; Schieffer B; Meyer GP
    Int J Cardiol; 2011 Sep; 151(3):303-6. PubMed ID: 20598759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation to NT-ProBNP and remodeling after cardiac surgery.
    Boer BP; Vieira ML; Sampaio RO; Abensur H; Oliveira AG; Fernandes JR; Grinberg M
    Arq Bras Cardiol; 2013 May; 100(5):469-75. PubMed ID: 23579620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of NT-proBNP in assessment of right ventricular function in children after tetralogy of Fallot correction - a preliminary study.
    Pietrzak R; Werner B
    Kardiol Pol; 2009 Apr; 67(4):378-83. PubMed ID: 19492250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma natriuretic peptide levels reflect changes in heart failure symptoms, left ventricular size and function after surgical mitral valve repair.
    Feringa HH; Poldermans D; Klein P; Braun J; Klautz RJ; van Domburg RT; van der Laarse A; van der Wall EE; Dion RA; Bax JJ
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):159-65. PubMed ID: 16941223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age.
    van den Berg J; Strengers JL; Wielopolski PA; Hop WC; Meijboom FJ; de Rijke YB; Boomsma F; Bogers AJ; Pattynama PM; Helbing WA
    Int J Cardiol; 2009 Apr; 133(3):364-70. PubMed ID: 18495276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
    Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
    J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of right atrium dimension on adverse outcome after pulmonary valve replacement in repaired Tetralogy of Fallot patients.
    Ait-ALi L; Marrone C; Salvadori S; Federici D; Pak V; Arcieri L; Passino C; Santoro G; Festa P
    Int J Cardiovasc Imaging; 2020 Oct; 36(10):1973-1982. PubMed ID: 32462447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognostic value and serial changes of plasma N-terminal prohormone B-type natriuretic peptide in patients undergoing transcatheter aortic valve implantation.
    Ribeiro HB; Urena M; Le Ven F; Nombela-Franco L; Allende R; Clavel MA; Dahou A; Côté M; Laflamme J; Laflamme L; DeLarochellière H; DeLarochellière R; Doyle D; Dumont E; Bergeron S; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2014 Mar; 113(5):851-9. PubMed ID: 24528616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular remodeling after conduit replacement in patients with corrected tetralogy of Fallot - evaluation by cardiac magnetic resonance.
    Guné H; Sjögren J; Carlsson M; Gustafsson R; Sjöberg P; Nozohoor S
    J Cardiothorac Surg; 2019 Apr; 14(1):77. PubMed ID: 30987651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
    Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
    Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction.
    Khositseth A; Manop J; Khowsathit P; Siripornpitak S; Pornkul R; Lolekha P; Attanawanich S
    Pediatr Cardiol; 2007; 28(5):333-8. PubMed ID: 17607502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
    Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
    Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical and transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: cardiac magnetic resonance imaging characteristics and morphology of right ventricular outflow tract.
    Ozkok S; Ciftci HO; Kose KB; Yucel IK; Sasmazel A; Celebi A; Pekkan K
    Pediatr Radiol; 2023 Aug; 53(9):1863-1873. PubMed ID: 37010546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic markers in patients undergoing transcatheter implantation of Venus P-valve: Experience in Taiwan.
    Lin MT; Chen CA; Chen SJ; Chiu SN; Lu CW; Wu MH; Wang JK
    J Formos Med Assoc; 2021 May; 120(5):1202-1211. PubMed ID: 33158698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.